Brazilian study seeking to cure HIV will resume by year-end 2021

The scientists developed a treatment strategy that combined two types of drugs. The goal was to awaken the virus, bring it out of its latent state, and then eliminate it, using nicotinamide and auranofin.

RIO DE JANEIRO, BRAZIL - The head of the research group that eliminated the virus from the "São Paulo patient" reports that the new phase of studies is expected to begin at the end of the year.

The researcher and infectiologist at the Federal University of São Paulo (Unifesp), Ricardo Sophie Diaz, intends to begin the new phase of clinical trials with the treatment that eliminated HIV that causes AIDS in a resident of São Paulo.

In this new phase, the team led by Diaz will increase the number of participants in the clinical trial to 70, with . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?